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Adrenergic activation during electrophysiologic study
could potentially alter the electrophysiologic properties
of the arrhythmia substrate. However, the catechol-
amine response to ventricular tachycardia induction and
termination during electrophysiologic testing has to date
not been quantitated. Therefore, in 13 patients undergo-
ing electrophysiologic study, arterial plasma norepi-
nephrine and epinephrine were measured before, during
and 1, 3, 5, 10 and 15 minutes after ventricular tachy-
cardia induced by programmed stimulation and termi-
nated by a single 100J external countershock. Sinus rate
and the effective refractory period at the right ventric-
ular apex at a basic drive cycle length of 400 ms were
measured after the countershock at the same time in-
tervals used for the catecholamine measurements. The
mean ventricular tachycardia cycle length (± SD) was
187 ± 30 ms, and the mean duration of ventricular
tachycardia was 18 ± 4 seconds.
Plasma norepinephrine and epinephrine increased,
respectively, from a baseline of 286 ± 141 and 119 ±
40 pglml to 770 ± 330 (169%) and 597 ± 467 pg/ml
(402%), (p < 0.01) at 1 minute after the countershock.
The mean plasma norepinephrine and epinephrine levels
during ventricular tachycardia and at times greater than
1 minute after the shock did not differ significantly from
baseline levels. Sinus rate increased from a baseline of
During electrophysiologic testing, programmed ventricular
stimulation may result in the induction of rapid ventricular
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74 ± 13 to 103 ± 26/min (39%) at 1 minute after the
shock (p < 0.05) and then returned to baseline. Right
ventricular effective refractory period decreased from a
baseline of 236 ± 27 to 212 ± 23 ms ( -10%) and 226
± 25 ms (-4%) at 1 and 3 minutes, respectively, after
the countershock (p < 0.01), then returned to baseline.
In some patients, a 10 to 20 ms decrease in effective
refractory period persisted for up to 10 minutes. In an
additional six patients without inducible ventricular
tachycardia, plasma catecholamine levels did not change
during programmed ventricular stimulation.
These data indicate that ventricular tachycardia in-
duction and termination by a 100 J countershock result
in a mean threefold increase in plasma norepinephrine
level and a fivefold increase in plasma epinephrine level
that are short-lived « 3 minutes). This degree of ad-
renergic activation may be sufficient to significantly
shorten ventricular refractoriness and potentially affect
the results of subsequent attempts at programmed stim-
ulation. During an electrophysiologicstudy, a rest period
of 15 minutes after ventricular tachycardia termination
by countershock should be adequate to avoid catechol-
amine-induced changes in electrophysiologic properties
of the arrhythmia substrate.
(J Am Coil Cardiol1986;8:584-9l)
tachycardia which causes hemodynamic deterioration and
requires direct current countershock to terminate. It is rea-
sonable to expect that the induced ventricular tachycardia
or external countershock, or both, may activate the sym-
pathetic nervous system, with release of norepinephrine at
adrenergic synapses and secretion of epinephrine from the
adrenal medulla. However, no studies to date have examined
the catecholamine response to ventricular tachycardia in-
duction or external countershock during electrophysiologic
testing.
Exogenous catecholamines such as isoproterenol de-
crease the ventricular effective refractory period and may
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facilitate the induction of ventricular tachycardia by pro-
grammed ventricular stimulation (1-3). It is therefore pos-
sible that endogenous catecholamines released as a response
to ventricular tachycardia induction or external countershock
could alter the electrophysiologic properties of the under-
lying arrhythmia substrate and affect the results of subse-
quent programmed stimulation. The extent and duration of
these possible effects have to date not been investigated.
The purpose of this study was to quantitate the response
of arterial plasma norepinephrine and epinephrine to ven-
tricular tachycardia induction and termination by external
countershock during electrophysiologic testing. Serial ven-
tricular effective refractory period measurements after the
direct current countershock were used as an indicator of the
potential extent and duration of the electrophysiologic ef-
fects of the released catecholamines on ventricular myo-
cardium.
Methods
Patient characteristics. The subjects of this study were
13 consecutive patients not being treated with a beta-ad-
renergic blocking agent who underwent an electrophysio-
logic study in which ventricular tachycardia requiring a sin-
gle direct current countershock for termination was induced.
The clinical features of these patients are described in Table
1. The clinical indication for the electrophysiologic study
was a recent episode of aborted sudden death in six patients,
unexplained syncope in five patients and a history of sus-
tained ventricular tachycardia in two patients. There were
eight women and five men, with a mean age (± I SD) of
52 ± 19 years. Seven patients had coronary artery disease
and a history of myocardial infarction, three had hyper-
trophic cardiomyopathy, one had idiopathic dilated cardio-
myopathy and two had no identifiable structural heart dis-
ease. Congestive heart failure was present in six patients
who had a mean left ventricular ejection fraction of 0.24
± 0.07 (range 0.15 to 0.30) as determined by contrast or
radionuclide ventriculography. The seven patients who did
not have congestive heart failure had a mean ejection frac-
tion of 0.63 ± 0.14 (range 0.44 to 0.82).
Control patients without inducible tachycardia. The
catecholamine response to programmed ventricular stimu-
lation itself was determined in six additional patients who
underwent electrophysiologic study and did not have in-
ducible ventricular tachycardia. The clinical features of these
patients are described in Table 2. There were four men and
two women, with a mean age of 46 ± 18 years. Three
patients underwent electrophysiologic study for evaluation
of unexplained syncope, two because of a recent episode
of aborted sudden death and one because of a history of
sustained ventricular tachycardia. Three patients had coro-
nary artery disease and a history of myocardial infarction,
one had idiopathic dilated cardiomyopathy and two had no
identifiable structural heart disease. Congestive heart failure
was present in three patients who had a mean left ventricular
ejection fraction of 0.30 ± 0.06. The three patients without
congestive heart failure had a mean ejection fraction of 0.5
± 0.16.
Drug therapy at the time of electrophysiologic study is
described in Tables 1 and 2 .. nitrate therapy was discontin-
ued on the day of the study. Patients who had been treated
with a beta-adrenergic blocking agent within 1 month of the
electrophysiologic study were not included. All patients pro-
vided informed consent to participate in this study under a
Table 1. Clinical Features of 13 Patients Studied and Characteristics of Ventricular Tachycardia Induced by Programmed Stimulation
Induced YT
Age (yr) Heart Duration
Case & Sex Disease CHF Drugs LYEF CL (ms) (seconds)
I 5!M CAD Yes D 0.30 200 25
2 62M CAD Yes None 0.26 190 15
3 28F None No None 0.60 160 22
4 63F CAD Yes D,Fu 0.30 180 18
5 62M CAD No Nifedipine 0.44 170 21
6 73M CAD Yes D,Fu 0.14 280 22
7 33F IDC Yes D,Fu,C 0.26 170 18
8 71M CAD No Diltiazem 0.50 180 10
9 22F HCM No None 0.80 170 19
10 66F CAD Yes D,Fu,C 0.15 180 16
II 52F HCM No None 0.65 170 12
12 52F HCM No None 0.65 170 16
13 67F None No None 0.58 200 18
Mean 52 0.45 187 18
± SD 19 0.23 30 4
C = captopril; CAD = coronary artery disease; CHF = congestive heart failure; CL = cycle length; D = digoxin; F = female; Fu = furosemide;
HeM = hypertrophic cardiomyopathy; IDC = idiopathic dilated cardiomyopathy; LYEF = left ventricular ejection fraction; M = male; YT = ventricular
tachycardia.
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Table 2. Clinical Features and Plasma Catecholamine Levels During Programmed Ventricular Stimulation in Six Patients Without
Inducible Ventricular Tachycardia
Plasma Catecholamine Level (pg/rnl)
Age (yr) Heart Baseline After S2 and S3* After S.*
Case &Sex Disease CHF Drugs LVEF NE E NE E NE E
14 39F IDC Yes D,Fu,C 0.24 308 273 314 100 326 123
15 71M CAD No None 0.32 379 159 341 137 376 147
16 31M None No None 0.58 118 161 152 138 113 121
17 50M CAD Yes D,Fu 0.30 168 169 193 60 197 68
18 64F CAD Yes D,Fu 0.36 145 122 122 142 96 109
19 24M None No None 0.60 517 126 567 115 549 114
Mean 46 0.40 272 168 281t 115t 276t 114t
± SD 18 0.15 157 55 165 32 174 25
*At two right ventricular sites and two basic drive cycle lengths (600 or 500 ms and 400 ms). tp > 0.05 versus baseline. E = epinephrine; NE =
norepinephrine; S2 = single extrastimu1us; S3 = double extrastimuli; S. = triple extrastimuli; other abbreviations as in Table I.
protocol approved by the Institutional Review Board at the
University of Michigan.
Electrophysiologic study protocol. The electrophysi-
ologic study was performed with patients in the fasting state,
at least four half-lives after discontinuation of all antiar-
rhythmic drugs. No patient was premedicated with a sed-
ative or received a sedative during the course of the elec-
trophysiologic study. Two quadripolar electrode catheters
were inserted percutaneously into a femoral vein and po-
sitioned against the right ventricular apex and outflow tract.
A short cannula was inserted into a femoral artery for ob-
taining blood samples and for continuous monitoring of the
blood pressure. Electrocardiographic leads VI, I and III and
the intracardiac electrograms recorded at the right ventric-
ular apex and outflow tract were displayed on an oscillo-
scope and recorded at a paper speed of 25 mm/s with an
Electronics for Medicine VR-16 recorder. Programmed
stimulation was performed with a programmable stimulator
(Bloom Associates) using stimuli 2 ms in duration and twice
diastolic threshold in intensity.
Sustained ventricular tachycardia was defined as ven-
tricular tachycardia greater than 30 seconds in duration or
requiring countershock for termination. Nonsustained ven-
tricular tachycardia was defined as ventricular tachycardia
six complexes to 30 seconds in duration.
Programmed ventricular stimulation protocol. Using
six to eight beat basic drive trains at two different cycle
lengths (600 or 500 ms and 400 ms), programmed stimu-
lation was performed with a single extrastimulus and then
with double extrastimuli, first at the right ventricular apex,
then at the outflow tract. Programmed stimulation was then
performed with triple extrastimuli at the apex, then at the
outflow tract. The coupling intervals between extrastimuli
were changed in 10 ms decrements. The intertrain interval
was 3 to 4 seconds.
The end point for the stimulation protocol was the in-
duction of sustained ventricular tachycardia requiring a sin-
gle 100 J direct current countershock for termination. On
induction of sustained ventricular tachycardia, the patient's
level of consciousness was monitored, and the countershock
was delivered as soon as the patient became unresponsive
to verbal stimuli.
Before induction of the sustained ventricular tachycardia
that required countershock, nonsustained ventricular tachy-
cardia more than 3 seconds in duration or sustained ven-
tricular tachycardia not requiring direct current countershock
was not induced in any patient. If more than a single 100
J countershock was required to terminate the ventricular
tachycardia, the patient was not included in this study.
Catecholamine determinations. Two baseline samples
of blood (2.5 cc each) from the femoral artery were obtained
5 minutes apart after a 15 minute rest period following
placement of the electrode catheters within the right ven-
tricle. If ventricular tachycardia was not induced by pro-
grammed stimulation with single or double extrastimuli, a
blood sample was obtained immediately after completion
of stimulation with double extrastimuli. On induction of
sustained ventricular tachycardia, an attempt was made to
obtain a blood sample before countershock. This was fea-
sible in 10 patients in whom a blood sample was obtained
between 8 and 15 seconds after the onset of ventricular
tachycardia. Blood samples were then obtained at 1, 3, 5,
10 and 15 minutes after the countershock was delivered.
In the six patients who did not have inducible ventricular
tachycardia, a blood sample was obtained immediately on
completion of stimulation with double extrastimuli and again
on completion of the entire stimulation protocol. The du-
ration of the stimulation protocol was 20 to 25 minutes.
Plasma norepinephrine and epinephrine were measured
using a single isotope radioenzymatic assay (4). All samples
from a given patient were analyzed in the same assay.
Determination of sinus rate, arterial pressure and
ventricular effective refractory period. The sinus rate and
mean arterial pressure were determined from a 10 second
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sample of sinus rhythm at 1, 3, 5, 10 and 15 minutes after
the countershock. This was not possible in two patients who
developed atrial fibrillation or flutter after the countershock .
In nine patients the effective refractory period at the right
ventricular apex was determined at I, 3, 5, 10 and 15 min-
utes after ventricular tachycardia termination by counter-
shock. The effective refractory period was determined using
a basic drive cycle length of 400 ms. In none of these nine
patients was the electrode catheter at the right ventricular
apex repositioned in the course of this study. If the electrode
catheter became displaced, as evidenced by a marked in-
crease in pacing threshold and a change in fluoroscopic
position, the patient was excluded from the study.
Statistical analysis. The plasma norepinephrine and epi-
nephrine levels, sinus rate, arterial pressure and ventricular
effective refractory periods after external countershock were
compared statistically with corresponding baseline values
by analysis of variance for repeated measures using Dun-
nett' s multiple comparison procedure (5) . A paired t test
demonstrated no significant difference between the two
baseline norepinephrine and epinephrine levels, and there-
fore the average of the two baseline levels was used in the
analysis of variance. Baseline catecholamine levels in pa-
tients with and without congesti ve heart failure were com-
pared by Student's t test. Correlation coefficients were ob-
tained by linear regression analysis.
Results
Induced ventricular tachycardia. The mean cycle length
of the induced ventricular tachycardia was 187 ± 30. ms.
The induced tachycardia was unimorphic in 2 patients and
polymorphic in 11 patients . It was induced by a single
extrastimulus in 1 patient, double extrastimuli in 2 patients
and triple extrastimuli in 10 patients. The tachycardia was
induced by stimulation at the right ventricular apex in II
patients and at the outflow tract in 2 patients.
In each patient, the mean arterial blood pressure fell to
a level of 35 mm Hg or less within 10 seconds after the
initiation of ventricular tachycardia. The mean duration of
the tachycardia before termination by external countershock
was 18 ± 4 seconds (range 10 to 25) (Table 1).
Baseline plasma catecholamine levels. The mean base-
line norepinephrine and epinephrine levels among the 19
patients in this study were 276 ± 141 and 134 ± 50 pglml,
respectively. There was no significant difference in the base-
line norepinephrine and epinephrine levels between the 9
patients who had congestive heart failure (246 ± 114 and
129 ± 66 pg/ml, respectively), and the 10 patients without
congestive heart failure (303 ± 162 and 140 ± 32 pg/ml ,
respectively) (p > 0.05) . Similarly , there was no difference
in these levels between the 10 patients who were being
treated with digoxin, furosemide, captopril, nifedipine or
diltiazem and the 9 patients who were not. There was no
significant correlation between left ventricular ejection frac-
tion and the baseline norepinephrine or epinephrine levels.
Plasma catecholamines in patients without inducible
ventricular tachycardia. The mean baseline norepin-
ephrine and epinephrine levels were 272 ± 157 and 168
± 55 pg/ml, respectively , in the six patients without in-
ducible ventricular tachycardia (Table 2). There was no
significant change in these levels after programmed stim-
ulation with one and two extrastimuli , or after programmed
stimulation with three extrastimuli.
Plasma catecholamines in patients with inducible ven-
tricular tachycardia. The mean baseline norepinephrine
and epinephrine levels in the 13 patients who had inducible
venticular tachycardia were 286 ± 141 and 119 ± 40
pg/rnl, respectively. In the nine patients in whom ventricular
tachycardia was induced by programmed stimulation with
triple extrastimuli, there was no change from baseline in
the norepinephrine or epinephrine level after completion of
programmed stimulation with one or two extrastimuli.
After the induction of ventricular tachycardia , but before
the external countershock , the plasma norepinephrine level
increased by at least twofold in three patients (Cases 8 to
10); in two of these three patients, the plasma epinephrine
level also increased at least twofold . However, among the
other 10patients whose catecholamine levels were measured
during ventricular tachycardia before the countershock, there
was no significant increase in the mean plasma norepi-
nephrine or epinephrine level (Fig, I , Table 3).
The mean norepinephrine and epinephrine levels were
consistently greater than baseline at I minute after the ex-
ternal countershock (p < 0.01) (Fig . 1, Table 3) . Overall,
there was approximately a threefold increase in the mean
norepinephrine level and a fivefold increase in the mean
epinephrine level. Both norepinephrine and epinephrine lev-
els then fell rapidly and were not significantly greater than
baseline at 3, 5, 10 or IS minutes after the external coun-
tershock. There was not a direct correlation between the
duration of ventricular tachycardia and the plasma norepi-
nephrine or epinephrine level during ventricular tachycardia
or at I minute after countershock .
Changes in arterial pressure. The mean arterial pres-
sure was 90 ± 12 mm Hg at baseline, and it fell to 28 ±
4 mm Hg (p < 0.01) during ventricular tachycardia. It
increased significantly over baseline after the countershock
(to 110 ± 18 mm Hg at I minute [p < 0 ,01], 100 ± 15
mm Hg at 3 minutes [p < 0.01) and 97 ± 15 mm Hg at
5 minutes [p < 0.05)) and then returned to baseline.
Changes in sinus rate and ventricular refractoriness.
The baseline sinus rate was 74 ± 13/min. There was a
significant increase to 103 ± 26/min at I minute after the
external shock (p < 0.05) (Fig . 2). The mean sinus rate at
subsequent time intervals after the external countershock
was not significantly different from baseline.
The mean baseline right ventricular effective refractory
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Figure 1. Plasma epinephrine (Epi) and
norepinephrine (NE) levels (mean ::':: I
SD) during induced ventricular tachycar-
dia (VT) and after a 100 J countershock.
Probability (p) values refer to comparison
with baseline.
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period was 236 ± 27 ms. There was a significant decrease
from baseline at I and 3 minutes after the external coun-
tershock (to 212 ± 23 and 226 ± 25 rns, respectively [p
< 0.01] [Fig. 2, Table 4]). At subsequent time intervals
after external countershock, it did not differ from baseline;
however, in some patients a 10 to 20 ms decrease in the
ventricular effective refractory period persisted for up to 10
minutes (Table 4).
Correlations between catecholamine levels and sinus
rate or ventricular refractoriness. There was not a sig-
nificant correlation in the baseline state between the nor-
epinephrine or epinephrine level and the sinus rate or the
ventricular effective refractory period. At I minute after
external countershock, when the norepinephrine and epi-
nephrine levels were at their highest, there was not a sig-
nificant correlation between these levels and the sinus rate
Table 3. Plasma Catecholamine Response to Ventricular Tachycardia Induction and Termination by External Countershock
in 13 Patients
During VT, After One 100 J Countershock (pg/rnl)Baseline Before
(pg/rnl) Shock (pg/ml) I Minute 3 Minutes 5 Minutes 10 Minutes 15 Minutes
Case NE E NE E NE E NE E NE E NE E NE E
I 248 94 ND ND 593 299 229 83 240 94 246 105 228 94
2 270 55 411 44 645 222 344 74 372 54 344 36 314 43
3 328 204 433 102 868 608 501 185 366 91 344 173 503 187
4 99 104 93 106 325 302 150 95 90 66 90 66 61 36
5 154 129 191 117 448 485 223 168 121 129 117 140 113 134
6 230 76 ND ND 469 184 151 55 261 86 184 73 184 81
7 257 100 255 102 638 906 398 296 319 179 350 154 358 182
8 443 137 1,208 975 1,227 518 722 238 573 181 489 163 458 148
9 216 146 455 651 975 1,292 219 191 230 238 233 277 219 115
10 494 166 950 198 869 399 711 183 568 123 543 149 388 146
II 194 100 ND ND 1,372 1,781 282 273 257 154 256 120 236 128
12 133 145 139 92 392 384 142 110 119 129 109 76 103 110
13 548 91 601 65 1,053 385 767 142 673 107 643 295 532 68
Mean 286 119 474t 245t 760* 597* 372t 161t 322t 125t 304t 140t 284t 113-;-
± SD 141 40 361 311 330 467 230 77 185 52 172 77 155 48
*p < 0.01 versus baseline; tp > 0.05 versus baseline. ND = not determined; other abbreviations as in Tables I and 2.
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Figure 2. Sinus rate and right ventricular effecti ve
refractory period (RVERP) after termination of ven-
tricular tachycard ia by a 100 J countershock . Shown
are mean values ± I SD. Probabilit y (p) values refer
to comparison with baseline.
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or ventricular effective refractory period . There was also
not a significant correlation between the change in norepi-
nephrine or epinephrine level from baseline to I minute
after external countershock and the corresponding change
in sinus rate or ventricular effecti ve refractory period , when
these values were expre ssed either in absolute terms or as
percent change .
Discussion
Catecholamine response. No prior studies have quan-
titated the catecholamine response to ventricular tachycardia
induction or termination during electrophysiologic testing.
The results of the present study demonstrate that, after the
induction of rapid ventricular tachycardia that results in loss
of consciousness and which is terminated by a single 100
J external countershock, I minute later there is approxi-
mately a threefold increase in the mean arterial plasma nor-
epinephrine level and approximately a fivefold increase in
the mean epinephrine level. These plasma catecholamine
levels are comparable with levels achieved during moder-
ately severe exercise (6) . The increase in plasma catechol-
amines after countershock is short-lived, and by 3 minutes
after the external countershock the mean norepinephrine and
epinephrine levels are no longer significantly greater than
baseline values.
Changes in ventricular refractoriness. In association
with the marked but brief increase in norepinephrine and
epinephrine levels , there was a 10 to 40 ms decrease in the
right ventricular effective refractory period. The temporal
association between the increase in plasma catecholamines
and the decrease in ventricular refractoriness suggests that
the latter was caused by adrenergic activation. When achieved
by infusion of epinephrine, plasma epinephrine levels in the
same range observed in response to countershock are as-
Table 4. Changes in the Right Ventricular Effecti ve Refractory Period (at a basic drive cycle length of 400 ms) After External
Countershock in Nine Patients
Baseline
ERP After Countershock (ms)
Case ERP (ms) 1 Minute 3 Minutes 5 Minute s 10 Minut es 15 Minute s
5 230 190 220 230 230 230
6 290 260 280 280 290 290
7 190 180 190 190 190 190
8 230 220 230 230 230 240
9 250 220 220 240 240 250
10 230 220 230 230 230 230
II 230 200 210 210 210 220
12 250 220 240 250 250 250
13 220 200 210 220 220 220
Mean 236 212* 226* 23It 232t 23M
:!: SD 27 23 2S 2S 28 27
*p < 0.01 versus baseline ; tp > 0.05 versus baseline. ERP = effective refr actory period.
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sociated with significant cardiovascular effects (6). Fur-
thermore, changes in the right ventricular effective refrac-
tory period comparable with the changes observed in the
present study have been reported to occur after administra-
tion of isoproterenol in doses sufficient to facilitate the in-
duction of ventricular tachycardia during electrophysiologic
testing (2,3).
Whereas the increase in the mean catecholamine levels
and the mean sinus rate lasted only I minute after the coun-
tershock, the decrease in the mean ventricular effective re-
fractory period persisted for 3 minutes and in some patients
it did not return to baseline values until 15 minutes after
the countershock. This suggests that the effect of catechol-
amines on the effective refractory period may lag behind
changes in the plasma catecholamine levels and sinus rate.
The observation that mean arterial pressure remained sig-
nificantly elevated for 5 minutes after the countershock pro-
vides additional evidence that the cardiovascular effects of
adrenergic activation may persist for several minutes. These
findings indicate that when rapid ventricular tachycardia
requiring direct current countershock is induced during an
electrophysiologic study, a rest period of 15 minutes is
advisable to avoid catecholamine-induced changes in elec-
trophysiologic properties that could potentially affect the
results of subsequent attempts at programmed ventricular
stimulation.
Effects of programmed stimulation. Because cate-
cholamine levels did not increase during the course of pro-
grammed ventricular stimulation in the six patients who did
not have inducible ventricular tachycardia, the increase in
norepinephrine and epinephrine that occurred in the patients
who had inducible ventricular tachycardia cannot be attrib-
uted to the effects of programmed ventricular stimulation.
Although no other studies have investigated the catechol-
amine response to programmed ventricular stimulation,
Schwartz et al. (7) measured the catecholamine response to
sustained atrial pacing and also found no change in arterial
catecholamine levels.
Cathecholamine response to ventricular tachycardia.
It is unclear whether the increase in catecholamines was
caused primarily by the ventricular tachycardia or by the
100 J countershock used to terminate the ventricular tachy-
cardia. Although the blood pressure during ventricular
tachycardia fell to a very low level in all patients, in most
patients an appreciable rise in norepinephrine and epin-
ephrine levels was not detected before the external coun-
tershock. However, because of the short interval between
the onset of ventricular tachycardia and the time of blood
sampling, and because of the severe circulatory stasis that
presumably was present before termination of the ventricular
tachycardia by countershock, the absence of a detectable
rise in the arterial plasma norepinephrine and epinephrine
levels does not necessarily rule out a catecholamine response
to ventricular tachycardia.
At I minute after the external countershock, when the
maximal changes in catecholamine levels and ventricular
effective refractory periods were detected, there was no
correlation between the magnitude of the increase in cate-
cholamines and the decrease in ventricular refractoriness.
It may be that plasma norepinephrine and epinephrine levels
do not accurately reflect myocardial catecholamine concen-
trations. Alternatively, it may be that there is not a linear
relation between catecholamine levels and the ventricular
effective refractory period.
Interpatient variability in catecholamine levels. There
was considerable interpatient variability in the baseline ar-
terial plasma norepinephrine concentration. Factors that may
have contributed to this variability include the presence of
congestive heart failure in some patients, variability in anx-
iety levels, the time of day that the study was performed,
the state of sodium balance and the extent of physical train-
ing (8-10).
Limitations. A limitation of this study is that, because
only a small proportion of norepinephrine released into the
synaptic cleft spills over into the general circulation, the
concentration of norepinephrine measured in arterial plasma
may have been grossly less than the concentration at its site
of action at the adrenergic synapse. A second limitation of
this study is that the direct effects of the catecholamine
response to ventricular tachycardia induction and termina-
tion on subsequent attempts at induction were not investi-
gated. A second induction of ventricular tachycardia shortly
after the first induction would have most likely necessitated
a second external countershock, and also would not have
allowed determination of the time course of changes in
catecholamines and refractory periods after the first ven-
tricular tachycardia induction and termination.
Conclusions. The validity of programmed ventricular
stimulation and electropharmacologic testing in patients with
inducible ventricular tachycardia depends on stability in the
electrophysiologic properties of the arrhythmia substrate and
the ability to reproducibly induce a given form of ventricular
tachycardia. The results of this study suggest that the testing
process itself, that is, the induction of ventricular tachy-
cardia and its termination by external countershock, results
in significant adrenergic activation and shortening of the
ventricular effective refractory period, factors that could
potentially affect the results of subsequent programmed
stimulation. However, even with increases in norepineph-
rine and epinephrine as great as 7-fold and 18-fold, re-
spectively, the duration of the catecholamine response is
brief, with the plasma catecholamine levels and the effective
refractory period returning to baseline within 15 minutes.
These findings suggest that a 15 minute rest period after
ventricular tachycardia induction and termination by a 100
J countershock should be adequate to avoid catecholamine-
induced changes in electrophysiologic properties of the ar-
rhythmia substrate.
lACC Vol. 8, No.3
September 1986:584-9 (
MORADY ET AL.
CATECHOLAMINES AND ELECTROPHYSIOLOGIC TESTING
591
We gratefully acknowledge the technical assistance of Marla Smith, Mary
Walley and David Cahallan, the computational assistance of Steven Schmaltz,
MPH and the secretarial assistance of Lisa Hackbarth,
References
I. Vargas G, Akhtar M, Damato AN. Electrophysiologic effects of iso-
proterenol on cardiac conduction system in man, Am Heart J
1975;90:25-34,
2. Reddy CP, Gettes LS. Use of isoproterenol as an aid to electric in-
duction of chronic recurrent ventricular tachycardia, Am J Cardiol
1979;44:705-13.
3. Freedman RA, Swerdlow CD, Echt DS, Winkle RA, Soderholm-
Difatte V, Mason JW. Facilitation of ventricular tachyarrhythmia in-
duction by isoproterenol. Am J Cardiol 1984;54:765-70.
4, Evans MI, Halter 18, Porte D Jr. Comparison of double- and single-
isotope enzymatic derivative methods for measuring catecholamines
in human plasma. Clin Chern 1978;24:567-70.
5. Dunnett CW. A multiple comparison procedure for comparing several
treatments with a control. J Am Statist Assoc 1955;50:1096-109.
6. Stratton JR, Pfeifer MA, Ritchie JL, Halter 18. Hemodynamic effects
of epinephrine: concentration-effect study in humans. J Appl Physiol
1985;58:1199-206.
7. Schwartz L, Sole MJ, Vaughan-Neil EF, Hussain NM, Catechol-
amines in coronary sinus and peripheral plasma during pacing-induced
angina in man. Circulation 1979;59:37-43.
8. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart
failure. Am J Cardiol 1978;41:233-43.
9, Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma
norepinephrine response to exercise in patients with congestive heart
failure. N Engl J Med 1962;267:650-4.
10. Goldstein DS. Plasma norepinephrine as an indicator or sympathic
neural activity in clinical cardiology, Am J Cardiol \98\ ;48: 1\47-54.
